We need
headline for here
Medical directors, physicians, and critical care teams alike have been anxious to both initiate and maintain high-flow nasal cannula therapy in the critical care and interfacility transport environments. However, that has been challenging, if not impossible, until now.
With the addition of the Phyxius family of integration carriers, clinicians can initiate advanced therapies at the bedside and continue to provide the established standard of care throughout all phases of patient movement, whether to the ER or the ICU, around the corner or across the globe, with uninterrupted care.
We need
headline for here
- Immediate care at the bedside in any transport scenario
- Uninterrupted care that maintains the established level of therapy
- No gaps in heated gas therapy
- No gaps in humidified gas therapy
- No gaps in aerosolized medication delivery
- Less risk for patient deterioration from interruption to the established standard of care, including preventing loss of mucociliary clearance
- Backup or mobile power supply
- Simultaneous delivery of powered aerosol therapy (Aerogen ultrasonic nebulizer therapy)
- Designed for safe operation and independently certified for safety
- Available for the Airvo 2
- Available for the Airvo 3
- Coming soon – The Hamilton T1